SG11201608497YA - Compositions comprising osteopontin derivatives for the inhibition of hair growth - Google Patents

Compositions comprising osteopontin derivatives for the inhibition of hair growth

Info

Publication number
SG11201608497YA
SG11201608497YA SG11201608497YA SG11201608497YA SG11201608497YA SG 11201608497Y A SG11201608497Y A SG 11201608497YA SG 11201608497Y A SG11201608497Y A SG 11201608497YA SG 11201608497Y A SG11201608497Y A SG 11201608497YA SG 11201608497Y A SG11201608497Y A SG 11201608497YA
Authority
SG
Singapore
Prior art keywords
osteopontin
inhibition
derivatives
compositions
hair growth
Prior art date
Application number
SG11201608497YA
Other languages
English (en)
Inventor
Jan Alenfall
Pontus Dunér
Anna Hultgårdh Nilsson
Ralf Paus
Stephen Edward Smith
Original Assignee
Follicum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Follicum Ab filed Critical Follicum Ab
Publication of SG11201608497YA publication Critical patent/SG11201608497YA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Birds (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
SG11201608497YA 2014-04-17 2015-04-17 Compositions comprising osteopontin derivatives for the inhibition of hair growth SG11201608497YA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1406989.2A GB201406989D0 (en) 2014-04-17 2014-04-17 Novel treatments
PCT/GB2015/051165 WO2015159099A1 (en) 2014-04-17 2015-04-17 Compositions comprising osteopontin derivatives for the inhibition of hair growth

Publications (1)

Publication Number Publication Date
SG11201608497YA true SG11201608497YA (en) 2016-11-29

Family

ID=50928957

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201608497YA SG11201608497YA (en) 2014-04-17 2015-04-17 Compositions comprising osteopontin derivatives for the inhibition of hair growth

Country Status (14)

Country Link
US (1) US20170143605A1 (enExample)
EP (1) EP3131528A1 (enExample)
JP (1) JP2017513856A (enExample)
KR (1) KR20160136342A (enExample)
CN (1) CN106413734A (enExample)
AU (1) AU2015248652A1 (enExample)
BR (1) BR112016023899A2 (enExample)
CA (1) CA2945930A1 (enExample)
GB (1) GB201406989D0 (enExample)
IL (1) IL248084A0 (enExample)
MX (1) MX2016013589A (enExample)
RU (1) RU2016144971A (enExample)
SG (1) SG11201608497YA (enExample)
WO (1) WO2015159099A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018202870A1 (en) * 2017-05-04 2018-11-08 Follicum Ab Peptides for treatment of diabetes
KR102091567B1 (ko) * 2018-06-15 2020-03-20 인하대학교 산학협력단 오스테오폰틴 단백질 단편을 유효성분으로 함유하는 뇌손상 예방 또는 치료용 약학 조성물
JP7553115B2 (ja) * 2018-11-07 2024-09-18 フォリクム エービー 糖尿病治療のためのペプチド断片
WO2020161255A1 (en) * 2019-02-07 2020-08-13 Dsm Ip Assets B.V. Novel method for reducing hair growth
EP3692978A1 (en) * 2019-02-07 2020-08-12 DSM IP Assets B.V. Novel method
US20220273765A1 (en) * 2019-04-24 2022-09-01 Follicum Ab Topical formulation
CA3168454A1 (en) 2020-02-25 2021-09-02 David K. Rosen Compositions and methods for stimulating hair growth

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753612A (en) * 1992-10-27 1998-05-19 Yissum Research Development Co. Of The Hebrew University Of Jerusalem Pharmaceutical composition and method for inhibiting hair growth by administration of activin or activin agonists
JP5043253B2 (ja) * 1999-10-21 2012-10-10 花王株式会社 脱毛剤及び外用剤
DE60131525T2 (de) * 2000-03-23 2008-09-25 Glaxo Group Ltd., Greenford Verfahren zum screening von inhibitoren für osteopontin
WO2008086449A2 (en) * 2007-01-09 2008-07-17 Oregon Health & Science University Synthetic osteopontin peptides and methods of use
GB2493540A (en) * 2011-08-10 2013-02-13 Follicum Ab Agents for stimulating hair growth in mammals

Also Published As

Publication number Publication date
US20170143605A1 (en) 2017-05-25
RU2016144971A3 (enExample) 2018-11-30
KR20160136342A (ko) 2016-11-29
EP3131528A1 (en) 2017-02-22
BR112016023899A2 (pt) 2018-06-05
RU2016144971A (ru) 2018-05-17
CN106413734A (zh) 2017-02-15
MX2016013589A (es) 2017-07-04
IL248084A0 (en) 2016-11-30
CA2945930A1 (en) 2015-10-22
JP2017513856A (ja) 2017-06-01
GB201406989D0 (en) 2014-06-04
AU2015248652A1 (en) 2016-10-20
WO2015159099A1 (en) 2015-10-22

Similar Documents

Publication Publication Date Title
IL280568A (en) Hair growth preparation containing minoxidil
IL246681A0 (en) Materials and preparations containing them for use in immunotherapy
EP3166574A4 (en) Cosmetic compositions
EP3136857A4 (en) Crystalline form of baricitinib
HUE056172T2 (hu) Szelenoorganikus vegyületeket tartalmazó készítmények és eljárások alkalmazásukra
EP3201187A4 (en) Compositions and methods for inhibiting bmp
PT3102555T (pt) Composições de compostos e seus usos
HUE052556T2 (hu) Expandálható bevonó készítmények és alkalmazásaik
EP3122355A4 (en) Compositions and methods for inhibiting bmp
IL248084A0 (en) Preparations include osteopontin derivatives to prevent hair growth
SMT202100551T1 (it) Derivati di sobetirome
PL3113774T3 (pl) Kompozycje grapiprantu i sposoby ich zastosowania
IL270961A (en) Crystalline form of N-butyldeoxygalactonogirimycin
ZA201700518B (en) Use of active compound compositions
EP3203992A4 (en) Compositions and methods for increasing the bioavailability of one or more compounds
GB201614961D0 (en) Compounds and compositions for use
PT3125859T (pt) Composição filmogénia
ZA201705100B (en) Jasmonate derivatives and compositions thereof
SMT202100381T1 (it) Derivati di pirazolilamminobenzimidazolo come inibitori di jak
EP3188738A4 (en) Compositions and methods for the inhibition of chondrogenesis
GB201418410D0 (en) use of compositions of matter
HK1233497A1 (en) Compositions of selenoorganic compounds and methods of use thereof
GB201412359D0 (en) Composition of objects
GB201412089D0 (en) Composition of objects
IL243281A0 (en) Silicone polyurea coating preparations